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Canonical PI3Kγ signaling in myeloid cells restricts
Trypanosoma cruzi infection and dampens chagasic
myocarditis
Maria C. Silva1,2,12, Marcela Davoli-Ferreira1,2, Tiago S. Medina2, Renata Sesti-Costa2, Grace K. Silva2,
Carla D. Lopes2, Lucas E. Cardozo3, Fábio N. Gava4, Konstantina Lyroni5, Fabrício C. Dias2, Amanda F. Frade6,13,
Monique Baron6, Helder I. Nakaya 3, Florêncio Figueiredo7, José C. Alves-Filho1, Fernando Q. Cunha1,
Christos Tsatsanis 5, Christophe Chevillard8, Edecio Cunha-Neto 6,9,10, Emilio Hirsch 11,
João S. Silva2 & Thiago M. Cunha1
Chagas disease is caused by infection with the protozoan Trypanosoma cruzi (T. cruzi) and is
an important cause of severe inflammatory heart disease. However, the mechanisms driving
Chagas disease cardiomyopathy have not been completely elucidated. Here, we show that
the canonical PI3Kγ pathway is upregulated in both human chagasic hearts and hearts of
acutely infected mice. PI3Kγ-deficient mice and mutant mice carrying catalytically inactive
PI3Kγ are more susceptible to T. cruzi infection. The canonical PI3Kγ signaling in myeloid cells
is essential to restrict T. cruzi heart parasitism and ultimately to avoid myocarditis, heart
damage, and death of mice. Furthermore, high PIK3CG expression correlates with low
parasitism in human Chagas’ hearts. In conclusion, these results indicate an essential role of
the canonical PI3Kγ signaling pathway in the control of T. cruzi infection, providing further
insight into the molecular mechanisms involved in the pathophysiology of chagasic heart
disease.
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Chagas disease is caused by infection with the intracellularprotozoan parasite Trypanosoma cruzi (T. cruzi). Cur-rently, approximately 6–7 million people worldwide,
mostly in Latin America, are infected1,2. At present, due to
migration to North America, Europe, and Japan, it is a global
health concern3–6. The disease is characterized by an acute phase,
usually asymptomatic and with evident parasitemia detectable in
the bloodstream7. In most individuals, manifestations of the acute
phase disappear a few weeks after infection8, followed by the
chronic phase of infection. Although the chronic phase of Chagas
disease is most likely featured by the asymptomatic form,
approximately 30% of patients develop the cardiac form9. Life-
threatening chronic chagasic cardiomyopathy (CCC) is the most
severe manifestation of the disease, which is characterized by an
intense Th1 T-cell and macrophage-rich myocarditis, destruction
of myofibers, and alteration of cardiac function10,11. It can lead to
refractory heart failure and sudden death in a significant pro-
portion of patients. The molecular mechanisms involved in the
pathophysiology of chagasic heart disease are unclear.
Recognition of the parasite by resident and recruited leukocytes
activates several signaling pathways, including phosphatidylino-
sitol 3-kinases (PI3Ks) signaling, which is involved in different
cellular processes through the phosphorylation of lipids and
proteins12,13. Among the PI3K enzyme family, PI3Kγ signaling is
activated by the βγ subunit of G-protein-coupled receptors and
plays an important role in leukocyte functions, inflammation, and
heart dysfunction14.
Here, we show that the canonical PI3Kγ is involved in the
pathophysiology of chagasic heart disease. The canonical PI3Kγ
pathway is upregulated in both human chagasic hearts and hearts
of acutely infected mice. Deficient mice in the canonical PI3Kγ
signaling are more susceptible to T. cruzi infection. The canonical
PI3Kγ signaling in myeloid cells restricts heart parasitism and
avoids heart damage and death of mice. Furthermore, high
PIK3CG expression correlates with low parasitism in human
chagasic hearts. These data identify a previously unrecognized
role of the canonical PI3Kγ signaling pathway in the control of T.
cruzi infection, providing further insight into the molecular
mechanisms involved in chagasic heart disease.
Results
Canonical PI3Kγ signaling protects from T. cruzi infection. We
initially examined the expression and activation of PI3Kγ sig-
naling in the heart tissue of T. cruzi-infected mice. For this
purpose, we performed analysis of the cardiac tissue tran-
scriptome from T. cruzi Y strain-infected C57BL/6 mice pre-
viously obtained by our group15 (GSE41089). Data revealed that
the expression of Pik3cg (P= 4.0E-3; unpaired t-test) and Pik3cd
(P= 7.4E-6; unpaired t-test) genes, but not Pik3ca, are upregu-
lated in the heart tissue of T. cruzi-infected mice 18 days post
infection (dpi) (Fig. 1a). Corroborating our transcriptome ana-
lysis, heart tissue of infected C57BL/6 mice showed an increased
mRNA expression of Pik3cg and Pik3cd genes, but not Pik3ca,
compared to heart samples from uninfected mice (Fig. 1b). Fol-
lowing activation, PI3Kγ promotes downstream signaling
through the protein kinase B (AKT) pathway16. The phos-
phorylated forms of AKT (pAKT) were thus studied as markers
of the canonical PI3Kγ signaling activation. AKT is a family of
kinases consisting of three isoforms of AKTs, AKT1, AKT2, and
AKT3 encoded by independent genes. AKT1 and AKT2 are
expressed in leukocytes and have been implicated in the immune
response17. In this context, we sought to investigate whether
PI3Kγ signaling was enhanced in the heart tissue of T. cruzi-
infected mice through the measurement of pAKTs (pAKT1 and
pAKT2). Although the infection does not change the expression
levels of Akt1 and Akt2 mRNA (Supplementary Fig. 1a, b) and
proteins (Fig. 1c, d), the phosphorylated forms of these proteins
are upregulated in the heart tissue of infected mice compared to
the uninfected group (Fig. 1c, d). These results indicate that after
infection with T. cruzi, PI3Kγ signaling is upregulated in the heart
of infected mice.
To evaluate whether PI3Kγ signaling pathways contribute for
the pathogenesis of chagasic disease, we took advantage of the
experimental mouse model of this disease. In this context, wild-
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Fig. 1 The PI3Kγ signaling is enhanced in the heart tissue of mice after experimental infection with T. cruzi. a Transcriptome analysis for the expression of
Pik3ca, Pik3cd, and Pik3cg genes in non-infected C57BL/6J mice or 18 days post infection with T. cruzi. b RT-PCR analysis of the mRNA expression of Pik3ca,
Pik3cb, Pik3cd, and Pik3cg genes in the heart tissue of C57BL/6 non-infected mice (n= 7) or 18 days post infection with T. cruzi Y strain (n= 11). Gapdh was
used as a housekeeping gene. c Representative western blots and analysis of phosphorylated (p) and total (t) AKT1 expression in the heart tissue of non-
infected C57BL/6 mice or 18 days post infection with T. cruzi (n= 6). GAPDH was used as a loading control. d Representative western blots and analysis of
phosphorylated (p) and total (t) AKT2 expression in the heart tissue of non-infected C57BL/6 mice or 18 days post infection with T. cruzi (n= 6). GAPDH
was used as a loading control. AU refers to arbitrary units (c, d). *P < 0.05, **P < 0.01, ***P < 0.001, and ns= no statistical significance (unpaired Student’s
t-test in b–d). Data are representative of two (b–d) independent experiments (mean ± s.e.m in b–d)
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type (WT) and Pik3cg−/− mice were infected with T. cruzi Y
strain. Unlike C57BL/6 WT mice, which had a slight reduction in
their body weight during infection, Pik3cg−/− mice presented a
significant reduction in their body weight starting at 9th day after
infection and progressively worsened (Fig. 2a). Moreover,
differently of the WT-infected mice, which presented 100% of
survival, all the infected Pik3cg−/− mice succumbed until 30 dpi
(Fig. 2b). Remarkably, heterozygous Pik3cg+/− mice were
protected from death caused by T. cruzi infection when compared
with homozygous Pik3cg−/− mice (Supplementary Fig. 2).
Although biological activities of PI3Kγ have been ascribed mainly
by its ability to convert PIP2 into PIP3, there is also evidence that
PI3Kγ can act as a scaffold protein, independently of the kinase
function18. In this context, we infected mutant mice carrying a
catalytically inactive PI3Kγ (Pik3cgKD/KD)18. Similarly to
Pik3cg−/− mice, Pik3cgKD/KD mice were also susceptible to T.
cruzi infection (Fig. 2c). In agreement with genetic inhibition of
the PI3Kγ catalytic activity, pharmacological inhibition of PI3Kγ
activity in WT mice with a partial selective PI3Kγ isoform
inhibitor, AS605240, increased the weight loss and mortality
when compared to vehicle-treated mice (Supplementary Fig. 3a,
b). Despite of having a high mortality rate, Pik3cg−/− and
Pik3cgKD/KD mice showed similar numbers of circulating
parasites in the blood across the whole time course compared
to WT mice (Fig. 2d, e), suggesting that the inefficient control of
the systemic parasitemia is not the cause of the increased Pik3cg
−/− and Pik3cgKD/KD mice mortality. To evaluate in which cell
type (cardiomyocytes or hematopoietic cells/leukocytes) PI3Kγ
signaling is important for the pathophysiology of chagasic heart
disease, bone marrow (BM) chimeric mice were generated.
Interestingly, the transfer of BM from WT mice to irradiated
Pik3cg−/− mice protected recipient mice from T. cruzi infection-
induced death (Fig. 2f). These data suggest that an integral PI3Kγ
signaling pathway in hematopoietic cells/leukocytes is central for
the control of T. cruzi infection.
PI3Kγ protects from T. cruzi infection-induced cardiac
damage. To elucidate the cause of the increased susceptibility to
T. cruzi infection by Pik3cg−/− mice, we analyzed whether these
animals developed heart complications. The heart damage was
quantified by serum CK-MB activity, an enzyme located in the
cytosol of the cardiomyocytes that is released into the blood after
heart damage19. The activity of CK-MB was significantly
increased in T. cruzi-infected Pik3cg−/− mice compared with its
activity in WT mice (Fig. 3a), indicating an enhancement of the
heart damage in Pik3cg−/− mice. Pik3cgKD/KD mice also showed
high levels of serum CK-MB after T. cruzi infection (Fig. 3b).
Further supporting heart dysfunction in Pik3cg−/− mice after
infection, echocardiography revealed a concentric hypertrophy,
along with a clear reduction in left ventricle diameter and cardiac
output and no reduction in ejection fraction (Fig. 3c–g). These
findings are indicative of a pathological adaptation of the heart
leading to heart failure with preserved left ventricular ejection
fraction20,21. Overall, the preceding data suggest that the cano-
nical PI3Kγ signaling pathway protects mice from T. cruzi
infection-induced heart damage and dysfunction.
Chagasic myocarditis is enhanced in PI3Kγ-deficient mice. To
further understand why the canonical PI3Kγ signaling pathway
protects mice from T. cruzi-induced heart damage and dysfunc-
tion, we next analyzed heart myocarditis in these mice. Although
PI3Kγ signaling is very important for leukocyte migration in
several models of inflammation22–25, histopathological analysis of
the heart tissue from T. cruzi-infected Pik3cg−/− mice revealed an
increase in leukocytes infiltration in comparison to WT mice
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Fig. 2 PI3Kγ signaling in hematopoietic cells is essential for mouse resistance to T. cruzi infection. a–c Body weight (a) and survival rate of C57BL/6 WT (n
= 10) and Pik3cg−/− (n= 10) (b) or Pik3cgKD/KD (n= 10) (c) mice infected with 103 trypomastigote forms of T. cruzi Y strain. d, e Blood parasitemia of WT
and Pik3cg−/− (d) or Pik3cgKD/KD (e) mice infected with 103 trypomastigote forms of T. cruzi Y strain. f Survival rate of chimera mice infected with 500
trypomastigote forms of T. cruzi Y strain. *P < 0.05, ***P < 0.001, and ns= no statistical significance (unpaired Student’s t-test in a, d, e and Mantel–Cox
log-rank test in b, c, f). Data are representative of two (f) of three (a–e) independent experiments (mean ± s.e.m in a, d, e)
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(Fig. 4a). In agreement with this finding, multiplex analyses of
cytokines/chemokines profile in the heart tissue of Pik3cg−/−
(Fig. 4b and Supplementary Table 1) and Pik3cgKD/KD (Supple-
mentary Fig. 4 and Supplementary Table 2) mice revealed an
increase in the levels of pro-inflammatory cytokines (e.g., TNF,
IFN-γ, and IL-6), and chemokines (e.g., RANTES, MCP-1, and
MIP-1α), whereas anti-inflammatory cytokines are down-
regulated (e.g., IL-10 and IL-13) when compared to infected WT
mice. At the same period of infection, the production of pro-
inflammatory and anti-inflammatory cytokines in the blood and
spleen was not different between WT and Pik3cg−/− mice
(Supplementary Fig. 5), suggesting that the PI3Kγ signaling
modulates inflammatory response in T. cruzi infection is specific
for the heart tissue. Supporting the enhanced myocarditis, the
number of CD4+ T-cells infiltrating the heart tissue of
Pik3cg−/−-infected mice was increased compared to WT mice
(Fig. 4c). Consistent with human chagasic cardiomyopathy26, the
real-time qPCR analysis in the heart revealed that CD4+ T-cells
mainly express the mRNA of the Th1-related transcription factor
Tbet, compared with Th2 (Gata3) and Th17 (Rorgt) cells
(Fig. 4d). In the absence of PI3Kγ, Tbet expression was increased
compared to WT controls (Fig. 4d). In addition, post treatment of
Pik3cg−/−-infected mice with a low dose of dexamethasone
(glucocorticoid) reversed their susceptibility to T. cruzi infection
(Fig. 4e). Collectively, these results indicate that enhanced myo-
carditis of infected Pik3cg−/− and Pik3cgKD/KD mice might
explain enhanced heart dysfunction and mortality.
Since PI3Kγ signaling appears to controls the production of
inflammatory mediators after infection with T. cruzi, we
investigated whether this effect might be related to the number
and suppressive function of regulatory T-cells. It was found that
the number of CD4+ Foxp3+ regulatory T-cells (Tregs) was not
different in the heart tissue of Pik3cg−/− and WT mice at 18 dpi
(Fig. 5a). Furthermore, the expression of the regulatory markers
in Tregs from infected heart of WT and Pik3cg−/−, Foxp3
(Fig. 5b, c), CTLA-4 (Fig. 5d), and CD39 (Fig. 5e) were also
similar. In addition, the PI3Kγ deficiency did not interfere with
the suppressor function of Tregs (CD4+ CD25+) cells isolated
from lymph nodes of naive mice (Fig. 5f). These results ruled out
that a disturbance in Tregs cells might explain the enhanced
chagasic myocarditis of Pik3cg−/− mice compared to WT
controls.
PI3Kγ signaling in myeloid cells reduces T. cruzi infection.
Because PI3Kγ signaling deficiency leads to a large number of
inflammatory cells and higher levels of inflammatory mediators
in the heart tissue of infected mice, we evaluated whether these
cells were able to control heart parasitism. Of note, an increased
number of amastigote nests were detected in the heart of
Pik3cg−/− mice when compared to WT mice (Fig. 6a). According
to the histological findings, the heart tissue of infected Pik3cg−/−
or Pik3cgKD/KD mice showed increased amount of parasite DNA
compared to infected WT mice (Fig. 6b, c). Supporting the
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Fig. 3 PI3Kγ is important for the heart function of T. cruzi-infected mice. a, b Serum CK-MB level of WT (n= 4), Pik3cg−/− (n= 4) (a) and Pik3cgKD/KD (n
= 7) (b) non-infected mice or 18 days post infection with 103 trypomastigote forms of T. cruzi Y strain. c Representative images of echocardiography in WT
(n= 6) and Pik3cg−/− (n= 6) non-infected mice or 18 days after infection with T. cruzi. Red arrows indicate diastolic ventricular diameter and yellow arrow
indicates diastolic ventricular wall thickness. d–g Diastolic left ventricle diameter (d), diastolic left ventricular posterior wall thickness (e), ejection fraction
(f), and cardiac output (g) of WT (n= 6) and Pik3cg−/− (n= 6) non-infected mice or 18 days after infection with 103 trypomastigote forms of T. cruzi Y
strain. *P < 0.05 and **P < 0.01 relative to WT-infected mice and #P < 0.05 and ##P < 0.01 relative to non-infected group (one-way ANOVA with Tukey’s
post hoc test in a, b, d–g). Data are representative of two independent experiments (mean ± s.e.m in a, b, d–g)
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hypothesis that Pik3cg−/− mice died due to uncontrolled heart
infection, post treatment (after parasitemia has falling down) with
benznidazole, the standard trypanocidal drug used for T. cruzi
infection27, protected Pik3cg−/−mice from death when compared
to vehicle-treated mice (Fig. 6d).
Heart T. cruzi parasitism control is orchestrated mainly by
infiltrating CD8+ T-cells and activated macrophages28–31. Thus,
we evaluated the presence and function of these cells to elucidate
the mechanisms of uncontrolled heart parasitism in Pik3cg−/−
mice. Numbers of infiltrating CD8+ T-cells in the heart of
Pik3cg−/−-infected mice did not differ from WT mice (Supple-
mentary Fig. 6a). In addition, the in vivo cytotoxic activity of
CD8+ T-cells in infected Pik3cg−/− mice was similar to WT mice
(Supplementary Fig. 6b), indicating that a defect in CD8+ T-cells
was not responsible for the Pik3cg−/− mice susceptibility to
control heart parasitism.
To further investigate why Pik3cg−/− mice failed to control
cardiac parasitism, we next determined whether a dysfunction in
migration and/or function of myeloid cells (e.g., macrophages)
could be involved. First, recruitment of CD11b+ cells into the
heart of infected Pik3cg−/− mice was similar to infected WT mice
(Fig. 7a). However, CD11b+ cells isolated from the heart of
Pik3cg−/− or Pik3cgKD/KD mice exhibited higher parasite levels
compared with CD11b+ cells isolated from WT mice (Fig. 7b).
Although the parasitism in CD11b− cells from Pik3cg−/− and
Pik3cgKD/KD mice was also higher, intracellular parasite levels
were lower than in CD11b+ cells (Fig. 7b). To further understand
the mechanisms by which Pik3cg−/−-deficient myeloid cells failed
to control intracellular T. cruzi infection, we investigated the
ability of bone marrow-derived macrophages (BMDMs) from
Pik3cg−/− mice to control the intracellular T. cruzi in vitro.
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Corroborating the in vivo findings, BMDMs from Pik3cg−/−
mice treated with IFN-γ were remarkably less effective in killing
the parasite than WT BMDMs (Fig. 7c). In addition, the number
of trypomastigote forms released into the supernatant from the
Pik3cg−/− BMDM culture was higher than in supernatant from
the WT BMDM culture (Fig. 7d). The increase in the nitric oxide
(NO) production by macrophages is the most important
mechanism involved in their microbicidal activity against T.
cruzi32,33. In association with the impaired ability to kill
intracellular T. cruzi, infected Pik3cg−/− BMDMs produced lower
amounts of NO compared to infected WT BMDMs (Fig. 7e). We
then proceeded to investigate whether the heart macrophages
from Pik3cg−/− mice had a reduced parasite-killing capacity
because they were not able to produce NO in vivo. PI3Kγ was
found to be essential for NO production in the heart of T. cruzi-
infected mice since the concentration of nitrate in the infected
heart tissue was reduced in Pik3cg−/− mice as compared with the
WT group (Fig. 7f). Then, we investigated whether PI3Kγ
signaling was also important for the microbicidal function of
human macrophages against T. cruzi infection in vitro. Corro-
borating the mouse data, pharmacological inhibition of PI3Kγ
reduced the ability of human macrophages (THP-1) to kill
intracellular parasites (Fig. 7g).
Finally, to validate that the canonical PI3Kγ signaling in myeloid
cells was important to counteract heart parasitism and confer
resistance to infection in vivo, mice harboring a conditional
deletion of AKT1 in LysM+ cells (Akt1−/−Lysmcre) were used34. Of
note, Akt1−/−Lysmcre mice were more susceptible to T. cruzi
infection when compared to control littermates (Fig. 8a). In
agreement, heart parasitism was not controlled in Akt1−/−Lysmcre
mice (Fig. 8b). Conversely, Akt2−/− mice were as resistant to T.
cruzi infection as WT mice (Fig. 8c), indicating that AKT1, but not
AKT2, was involved in the downstream events of PI3Kγ
signaling responsible for the control of T. cruzi infection. Taken
together, these results indicated that a canonical PI3Kγ/
AKT1 signaling deficiency in myeloid cells led to an inability to
control heart T. cruzi infection and ultimately avoid heart damage
and host death.
PI3Kγ signaling in human chagasic myocarditis. To translate
our findings in the mouse model to the human disease, we
examined the expression and activation of PI3Kγ signaling in the
heart samples of chagasic disease patients. Human heart tissue
transcriptome (GSE84796) revealed that the expression of
PIK3CG gene was upregulated in the samples from patients with
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Fig. 5 The absence of PI3Kγ does not affect the number and suppressive function of regulatory T-cells in the heart tissue of infected mice. a Representative
flow cytometry plots for the analysis of Foxp3 staining and quantification of the number of positive cells in the heart tissue of WT (n= 4) and Pik3cg−/− (n
= 3) naive mice or infected with T. cruzi Y strain. b PCR analysis of mRNA expression of Foxp3 gene in the heart tissue of WT (n= 4) and Pik3cg−/− (n= 4)
mice. Gapdh was used as a housekeeping gene. c–e Flow cytometry analysis measured by the mean fluorescence intensity (MFI) of the cell surface markers
Foxp3 (c), CTLA-4 (d), and CD39 (e) expressed in CD4+Foxp3+ cells from the heart tissue of infected of WT (n= 4) and Pik3cg−/− (n= 4) mice 18 days
after infection with 103 trypomastigote forms of T. cruzi Y strain. f In vitro T-cell suppression by Treg cells isolated from the lymph nodes of WT and
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CCC when compared to heart samples from healthy control
individuals (Ctl) (relative expression= 5.37; P= 1.0E-5; Student’s
t-test with the Benjamini–Hochberg method) or even samples
from patients with non-chagasic cardiomyopathy (idiopathic
dilated cardiomyopathy, DCM, GSE111544, Relative expression
= 6.60; P= 2.1E-8; Student’s t-test with the Benjamini–Hochberg
method) (Fig. 9a). None of the other members of the class 1 PI3K
family (α, β, and δ subunits) appeared to be modulated as dra-
matically as the PIK3CG gene (Fig. 9a). To validate the tran-
scriptome data, samples from human hearts were used for the
evaluation of PIK3CG expression by real-time PCR. Corrobor-
ating our transcriptome analyses, PIK3CG and PIK3CD expres-
sion were upregulated (Fig. 9b), whereas the expression of
PIK3CA and PIK3CB was similar in the heart samples from CCC
patients in comparison to those from healthy control individuals
or DCM patients (Fig. 9b). Next, we verified the activation of
PI3Kγ signaling in the chagasic human samples. Although there
was no change in AKT1 and AKT2 mRNA (GSE84796 and
validation—Supplementary Fig. 1c, d) and protein expression
(Fig. 9c, d), the activated forms of AKT1 and AKT2 (pAKT1 and
pAKT2) were increased in the heart tissue from CCC patients
compared to those from DCM patients or healthy controls
(Fig. 9c, d). To analyze the interactions between PI3Kγ and the
heart immune response, a correlation analysis was performed
using the transcriptome data set from CCC patients (GSE84796).
The expression of the PIK3CG gene positively correlated with the
expression of myeloid cells markers (CD11b, CD300a, and CD33)
and inflammatory mediators genes (Supplementary Fig. 7a–h),
indicating that the increased influx of leukocytes in chagasic
hearts might be the cause of the increase in PI3Kγ expression. To
validate these findings, real-time PCR was performed in the heart
samples. The expression of pro-inflammatory cytokines (TNF and
IFNG) and chemokines (CCL5/RANTES) was higher in heart
tissue of CCC patients compared with the DCM or control groups
(Supplementary Fig. 8a–c). In agreement, there was a positive
correlation in heart tissue of CCC patients between the expression
of the PIK3CG gene and the proinflammatory genes TNF (r2=
0.42; P= 0.16, Pearson’s test), IFNG (r2= 0.62; P= 0.061, Pear-
son’s test), and CCL5/RANTES (r2= 0.68; P= 0.042, Pearson’s
test) (Supplementary Fig. 8d–f).
Finally, we also analyzed the interaction between PI3Kγ
expression and heart parasitism to validate the hypothesis that
PI3Kγ participates in the mechanisms that control heart T. cruzi
infection. Real-time PCR analyses of T. cruzi DNA in the heart
samples of CCC patients revealed two distinct groups of patients
regarding the levels of parasitism. Some of them had low levels of
heart parasitism, which were almost undetectable, and others
showed significant parasitism (Fig. 10a). When we stratified these
two groups, we found that the expression of PIK3CG was much
higher in the group with low parasitism (Fig. 10b). Collectively,
these results indicated that similarly the findings obtained in the
mouse model of T. cruzi infection, PI3Kγ signaling was also
upregulated in the heart tissue of one group of chagasic disease
patients and that this signaling might also be acting as a
counteracting mechanism of heart T. cruzi parasitism.
Discussion
Characterization of the pathophysiological aspects of heart T.
cruzi infection and the mechanisms that lead to resistance or
susceptibility of the host is fundamental to understand the Chagas
disease and to propose novel targets to prevent the development
of the severe form of this disease. In this regard, identification of
the intracellular signaling pathways activated in response to T.
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cruzi infection is critical. In the present study, we investigated the
role of PI3Kγ signaling in the heart of T. cruzi-infected mice and
humans. Our findings indicate that canonical PI3Kγ/
AKT1 signaling is upregulated in the heart tissue of T. cruzi-
infected mice and humans with the Chagas disease. Finally, we
further demonstrated an essential role of the canonical PI3Kγ
signaling in myeloid cells (e.g., macrophages) to restrict heart
parasitism and consequently avoid heart inflammation/damage
and dysfunction.
The activation of PI3K signaling has been demonstrated during
in vitro infections of human and mouse macrophages with T.
cruzi35–37. To our knowledge, this is the first study to provide
further evidence that canonical PI3Kγ signaling, together with its
downstream pathway AKT1, is activated in the heart tissue from
chagasic patients and mice infected with T cruzi. Herein, we
found that in the absence of canonical PI3Kγ signaling in
hematopoietic cells, mice are highly susceptible to T. cruzi
infection, which is associated with an uncontrolled heart
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parasitism and exacerbated inflammatory response. Since PI3Kγ
pathway is activated by GPCRs, such as chemokine receptors, this
signaling is crucial for leukocyte migration, genetic or pharma-
cological inhibition of this kinase decreases the inflammation and
ameliorates the score in several models of inflammatory dis-
eases22–24,38. Our data showed that the ablation of PI3Kγ does
not inhibit the T. cruzi-induced leukocyte migration to the heart
tissue, suggesting that during T cruzi infection, leukocyte
migration is not mediated by canonical PI3Kγ signaling, and
other chemotaxis signaling events might play a role during the
infection.
It is established that PI3Kγ signaling also plays an important
role in cardiomyocytes physiology and that its absence can
aggravate some cardiomyopathies18,39. Our data indicate that the
participation of PI3Kγ signaling in the pathophysiology of cha-
gasic heart disease seems to be more related to its function in
heart-infiltrating myeloid cells. This result is apparently different
from the evidence showing that during the chronic phase of T.
cruzi infection, the PI3K/AKT/NO axis in cardiomyocytes con-
tributes to the development of electric dysfunction of cardio-
miocytes40. Nevertheless, these differences could be explained by
the different stage of the disease or even by different PI3K isoform
involved40. Furthermore, the impact of the PI3K/AKT/NO
pathway in cardiomyocytes on the in vivo outcome has been not
evaluated40.
Chagasic heart failure has been attributed to increased levels of
local or systemic pro-inflammatory cytokines/chemokines27. In
addition to the inability to restrict the heart parasitism, our data
showed an enhanced production of pro-inflammatory cytokines
and chemokines in the cardiac tissue of Pik3cg−/−mice. Although
this “cytokine storm” might be merely a consequence of uncon-
trolled parasitism, it seems strictly important for the increased
susceptibility. This hypothesis was supported by the findings that
treatment with a low dose of glucocorticoid is able to reverse
Pik3cg−/− mouse susceptibility. Nevertheless, we cannot elim-
inate the possibility that PI3Kγ signaling pathway directly dam-
pen the inflammatory response in the heart of infected mice. In
fact, a recent study has demonstrated that the activation of PI3Kγ
signaling counteracts inflammatory cytokines and chemokines
production by macrophages41.
The finding that canonical PI3Kγ signaling is also increased in
the heart tissue of CCC patients is consistent with the observed
tissue leukocyte infiltration. Furthermore, our finding that
patients with lower heart parasitism have higher cardiac expres-
sion of PI3Kγ supports our hypothesis that this kinase contributes
to the containment of T. cruzi infection. On the other hand, some
patients develop CCC despite having high expression/activation
of canonical PI3Kγ signaling and controlling the parasitism in the
heart. Nevertheless, as myocarditis is the prime process of CCC
progression42, partial control of heart parasitism due to PI3Kγ-
expressing myeloid cells occurs at the expense of tissue-damaging
inflammation, likely leading to myocarditis and the development
of cardiomyopathy in such chronically infected individuals.
Consistently, we propose that PI3Kγ signaling might be a pro-
tective mechanism that restricts heart parasitism to avoid a rapid
progression of the disease, which usually takes several years to
chronify. Finally, we hypothesize that alterations that change
PI3Kγ expression and/or function (due to polymorphisms,
mutations) could be a factor involved in the susceptibility of some
patients to developing cardiac forms of Chagas disease. Further
studies are necessary to test this hypothesis.
Collectively, the present study has demonstrated the crucial
role of the canonical PI3Kγ signaling for host resistance to T.
cruzi infection. Furthermore, the canonical PI3Kγ signaling in
heart-infiltrating myeloid cells is crucial for optimal microbicidal
activity that leads to the control of heart parasitism and to the
avoidance of exacerbated myocarditis and heart damage. In
conclusion, we believe that our data provided further insight into
the molecular mechanisms of the pathophysiology of chagasic
heart disease.
Methods
Animals. Female C57BL/6 WT, PI3Kγ-deficient mice (Pik3cg−/−)43, and PI3Kγ
kinase dead mutant mice (Pik3cgKD/KD)44 aged 6–8 weeks were bred and main-
tained at the animal facility of the Ribeirão Preto Medical School University of São
Paulo, Ribeirão Preto, Brazil. Female conditional Akt1−/−Lysmcre were generated
by crossing Akt1fl/fl mice34 (kindly provided by Prof. P. Tsichlis, Tufts University,
Boston, USA) and Lysmcre mice (Jackson Laboratories). Akt1−/−Lysmcre mice,
littermate controls and Akt2−/− mice45 (kindly provided by Prof. M. Birnbaum, U.
Pennsylvania, Philadelphia, USA) were maintained at the animal facility of the
Medical School, University of Crete and IMBB-FORTH, Greece. Pik3cg+/− mice
were generated by crossing Pik3cg−/− mice with C57BL/6 WT mice. The animals
were maintained in micro-isolator cages under standard conditions and fed with
food and water ad libitum. The Institutional Ethics Committee in Animal
Experimentation—CEUA of the Ribeirão Preto Medical School, University of São
Paulo (Protocol number 196/2009) and the Veterinary Department of the Crete
Region, Medical School, University of Crete and IMBB-FORTH, Heraklion, Crete,
Greece (Protocol number 27298/2014) approved the experimental protocols. Mice
were selected based on their genotype. All other criteria were not considered and as
such, randomized. We were not blinded to the mouse genotypes or group allo-
cations except where mentioned.
Mouse infection. All experiments were conducted using trypomastigote forms of
human isolated T. cruzi Y strain46. For in vitro experiments, parasites were grown
for 7–9 days in a fibroblast cell line LLC-MK2 (American Type Culture Collection-
ATCC®, cat. CCL-7™) and suspended in RPMI 1640 medium (Gibco-BRL Life
Technologies, Grand Island, NY, USA). For in vivo experiments, mice were
inoculated intraperitoneally with 103 bloodstream trypomastigote forms. From day
5 after infection, blood parasitemia was evaluated in 5 μl of blood from the tail vein
by counting 100 fields through direct observation under an optical microscope.
Additionally, the body weight of the mice was also measured. The survival rate was
assessed daily. Infected animals were excluded (pre-established) from the study
when parasitemia was not detected at day 9 post infection.
Real-time quantitative PCR. For RT-PCR, total RNA was isolated form heart
samples with TRIzol using the specific kit RNeasy mini kit (Qiagen), and cDNA
was synthesized with the ThermoScript RT-PCR system (Invitrogen). PCR was
carried with StepOnePlus (Applied Biosystems) using SYBR Green GoTaq qPCR
Fig. 7 Disruption of PI3Kγ signaling in human or murine macrophages harms the killing of intracellular T. cruzi. a Representative flow cytometry dot plots for
the analysis of CD11b staining and quantification of the absolute number of positive cells in the heart tissue of non-infected WT (n= 5) and Pik3cg−/− (n=
5) mice or 18 days post infection with 103 trypomastigote forms of T. cruzi Y strain. b Quantitative PCR analysis of nanogram of T. cruzi DNA presents in 1
ng of DNA from CD11b− and CD11b+ cells isolated from the heart tissue of WT and Pik3cg−/− or Pik3cgKD/KD-infected mice. c Representative images of
BMDMs stimulated with 0.1 or 1 ng of IFN-γ and infected for 48 h with trypomastigote forms of T. cruzi Y strain at MOI 3:1. Scale bars= 100 µm. d
Trypomastigote forms of T. cruzi Y strain released from culture of WT and Pik3cg−/− BMDM stimulated with 0.1 ng ml− of IFN-γ. Experiments were
performed in triplicate. e Nitrite quantification by Griess reaction in the supernatant of WT and Pik3cg−/− BMDMs stimulated with 1 ng of IFN-γ and
infected with T. cruzi Y strain at MOI 3:1. f Nitrate quantification in the heart tissue of WT (n= 7) and Pik3cg−/− (n= 7) naive mice or 18 days post
infection with 103 trypomastigote forms of T. cruzi Y strain. g Representative images of human macrophage lineage THP-1 cells treated with specific PI3Kγ
inhibitor AS605240 (1 µM) and infected with trypomastigote forms of T. cruzi Y strain at MOI 3:1. Scale bars= 20 µm. ns = no statistical significance
(unpaired Student’s t-test in a). *P < 0.05 relative to WT CD11b+ cells and #P < 0.05 and ##P < 0.01 relative to WT or Pik3cg−/− CD11b− cells (unpaired
Student’s t-test in b). *P < 0.05, **P < 0.01, and ***P < 0.001 (unpaired Student’s t-test c–g). Data are one experiment (g) or representative of two (a–d, f)
or three (e) independent experiments with similar results (mean ± s.e.m in a–g)
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MasterMix (Promega). The endogenous control Gapdh was used to normalize gene
expression. The sequences of the primers are shown in Supplementary Table 3.
Western blot analysis. Protein lysates from human or mouse heart samples were
prepared in RIPA buffer supplemented with a cocktail of protease and phosphatase
inhibitors (Cell Signaling). Equal amounts of total proteins were loaded and
separated in SDS-polyacrylamide gel. After electrophoresis, the proteins were
electrotransferred onto nitrocellulose membranes (0.2 μm, GE Healthcare) and
incubated for 1 h with 5% bovine serum albumin followed by overnight incubation
at 4 °C with primary antibody. Finally, the membranes were incubated for 1 h with
secondary antibodies conjugated to horseradish peroxidase. Immunoblots were
visualized with the Western Blotting Chemiluminescence Luminol (Pierce, Thermo
Fisher Scientific Inc.) using the ChemiDoc™ XRS System (Bio-Rad). The primary
antibodies used in the study were: phospho-AKT1 (1:600; Cell Signaling, cat. 9018);
total AKT1 (1:1000; Cell Signaling, cat. 2938); phospho AKT2 (1:600, Cell Sig-
naling, cat. 8599); total AKT2 (1:1000; Cell Signaling, cat. 3063); and GAPDH (1:
5000; Sigma-Aldrich, cat. G9545). Full scans of the original uncropped western
blots are shown in Supplementary Figs. 9 and 10.
Serum CK-MB activity assay. To evaluate cardiac damage, the activity of CK-MB
was measured in the sera of mice infected with T. cruzi. Quantification was per-
formed using a kinetic method with specific kit CK-MB Liquiform (Labtest®)
followed by read in spectrophotometer at 340 nm (EMAX Molecular Devices
Corporation®).
Echocardiography. Mice were anesthetized with 1.5% isofluorane (Forane® Iso-
flurane, USP) in an inhalation chamber. Body temperature was monitored, and
cardiac parameters were obtained through VEVO2100® machine using a 30MHz
transducer. Diastolic left ventricle diameter and ventricular posterior wall thickness
were evaluated in M mode; ejection fraction and cardiac output were calculated in
bidimensional mode.
Histological analysis. Heart samples were fixed in 10% buffered formalin solution
and, after 72 h, dehydrated in a crescent concentration of ethanol solutions and
embedded in paraffin. Blocks were sectioned at thickness of 5 μm and stained with
haematoxylin-eosin (H&E). Using a light microscope, the number of amastigote
nests was counted in 25 images of each animal of the group, the inflammation was
estimated with ImageTool 2.0 software (University of Texas Health Science Center,
TX, USA). The pathologist who performed the histological analysis was blinded to
the mice genotypes.
Treatment with PI3Kγ inhibitor. WT mice were divided in two groups and
treated subcutaneously with 30 mg kg− of PI3Kγ inhibitor AS605240 (5-Quinox-
alin-6-ylmethylene-thiazolidine-2,4-dione—Alexis®) or vehicle (2% DMSO)47.
Mice were treated once a day starting from the peak of parasitemia (day 9 of
infection) for 10 days.
Cytokines and chemokines measurement. Measurement of cytokines and che-
mokines in the heart tissue of mice was performed by Milliplex® (Merck Millipore)
assay in accordance with the manufacturer’s instructions.
Production of the cytokines IFN-γ, TNF-α, IL-10, and IL-4 (R&D Systems,
Minneapolis, MN) was assessed in the serum and spleen of WT and Pik3cg−/−
naive mice or 18 days after infection with 103 trypomastigote forms of T. cruzi Y
strain. Fragments of spleen were collected into vials with a protease inhibitor
cocktail (Complete, Roche), macerated, and centrifuged, and the supernatant
collected for cytokine quantification. Measurements were performed through by
ELISA assay, using specific kit (DuoSet®, R&D Systems) according to
manufacturer’s instructions.
FACS analysis. The mouse heart tissue was sliced into small pieces and digested
using Liberase TL (Roche) for 1 h at 37 °C/5% CO2. The obtained cells suspension
was filtered through a 40 µm cell strainer (Corning®), and isolated cells were
counted in a Neubauer chamber and then incubated with specific antibodies. The
following antibodies were used: APC-Cy7 rat anti-mouse CD45 (1: 200, clone 30-
F11, BD Biosciences, cat. 557659); FITC armenian hamster anti-mouse CD3 (1:250,
clone 145-2C11, eBioscience, cat. 11-0031-63); PercP rat anti-mouse CD4 (1:250,
clone RM4-5, BD Biosciences, cat. 553052); PE rat anti-mouse CD8a (1:250, clone
53-6.7, BD Biosciences, cat. 553033); Alexa Fluor® 647 rat anti-mouse Foxp3
(1:100, clone R16-715, BD Biosciences, cat. 563486); PE rat anti-CD11b (1:250,
clone M1/70, BD Biosciences cat. 553311); PE hamster anti-mouse CD152/CTLA-4
Clone (1:150, UC10-4F10-11, BD Bioscience, cat. 553720); PE/Cy7 anti-mouse
CD39 (1:250, clone Duha59 BioLegend, cat. 143806). For each sample, a minimum
of 1 million events were acquired using a BD FACSVerse cytometer driven by the
FACSuite software (BD Biosciences, San Diego, EUA). The obtained data were
analyzed using the software FlowJo version X (Tree Star, Inc.). Gating strategies for
flow cytometry analysis are schematically represented in Supplementary Fig. 11.
Heart CD11b+ and CD11b− cells isolation. The mouse heart tissue was sliced in
small pieces and digested using Liberase TL (Roche) for 1 h at 37 °C/5% CO2. The
obtained cell suspension was filtered through a 40-µm cell strainer (Corning®).
Isolated cells were stained with PE rat anti-CD11b (1:300; clone M1-70, BD
Biosciences, cat. 553311) and then incubated with anti-PE magnetic beads (Mil-
tenyi Biotec). The cell suspension was separated into CD11b+ and CD11b−
samples using MACS® cell separation columns (Miltenyi Biotec) according to the
manufacturer’s instructions.
Total genomic DNA extraction and parasitism analysis. Total genomic DNA
was extracted from 10 mg of CCC patients or mouse heart tissue or from mouse
heart CD11b+ and CD11b− cells using a specific kit (Wizard® SV Genomic DNA
Purification System Promega, cat. A2361) according to the manufacturer’s
instructions. Real-time PCR was performed to quantify the heart parasitism as
previously described48.
Treatment with dexamethasone. WT and Pik3cg−/− mice were infected with 103
trypomastigote forms of T. cruzi Y strain and treated intraperitoneally at day 9 post
infection with 2 mg Kg− and at days 12 and 15 with 1 mg Kg− of dexamethasone or
vehicle.
Treatment with benznidazole. Pik3cg−/− mice were infected with 103 trypo-
mastigote forms of T. cruzi Y strain and treated by gavage with 100 mg Kg− of
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Benznidazole (BNZ) or vehicle. Mice were treated once a day starting from the day
9 post infection for 10 days.
BM cells isolation and generation of chimeric mice. WT and Pik3cg−/− BM
stem cells were obtained by flushing the femur. Briefly, the bone was surgically
removed, and muscle tissue was scraped away from bone using a scissor and scalpel
blade. Subsequently, the epiphysis was cut, and the stem cells were removed from
the diaphysis by flushing with RPMI 1640 medium using a syringe with a 26-gauge
needle. Cells were centrifuged at 500 × g 10 min at 4 °C, suspended in PBS, counted
using trypan blue solution (Sigma-Aldrich®) and diluted at 2.5 × 107 ml− (5 × 106/
200 µl) for intravenous injection. To generate the chimeras, 10–12-weeks-old WT
and Pik3cg−/− mice were irradiated using a Cesium 137 source irradiator (Mark I
model 25) at 9 Gy. On the day after irradiation, the mice were divided at the
following groups: (1) WT mice repopulated with WT BM cells; (2) Pik3cg−/− mice
repopulated with WT BM cells; and (3) Pik3cg−/− mice repopulated with Pik3cg
−/− BM cells. After BM transplantation, the mice were treated for 15 days with the
antibiotic Ciprofloxacin hydrochloride diluted in drinking water at 10 mgml−.
After 2 months (period required for BM engraftment), mice were infected with 500
trypomastigote forms of T. cruzi Y strain, and the survival rate was followed every
day for 30 days.
Differentiation of BMDM and killing assay. BMDMs were obtained as previously
described49 and used for the killing activity assay, release of T. cruzi assay or NO
quantification after stimulation with IFNγ and T. cruzi. For the killing activity
assay, BMDMs (1.4 × 106 ml−) were incubated overnight with different con-
centrations of IFNγ (0.1 and 1 ng ml−) and macrophages posteriorly were infected
with T. cruzi at a MOI 3:1 ratio. After 4 h, the cells were washed to remove non-
internalized parasites and incubated for an additional 48 h at 37 °C a 5% CO2. The
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macrophage killing activity was evaluated by counting of intracellular amastigote
forms internalized per 150 cells. The counts were performed in a blinded manner.
For the release of T. cruzi assay, 2 × 105 cells were incubated with 1 ng ml− of IFNγ
and after 12 h were infected with T. cruzi at a MOI of 3:1. At days 4 and 5 post
infection trypomastigote forms of the parasites released to the medium were
counted50.
THP-1 cells differentiation and killing activity assay. Authenticated THP-1 cells
(cat. TIB-202, ATCC®, Manassas, VA, USA) monocytes lineage was differentiated
into macrophages using the method previously described by Daigneault et al51.
Briefly, THP-1 cells were cultured with 200 nM of PMA (Sigma-Aldrich; Merck
Millipore) for 3 h at 37 °C, 5% CO2. After incubation, PMA-containing medium
was removed, cells were plated in 24-wells plate at 2 × 105/well and the cells were
incubated for an additional 3 days. At the third day, THP-1 were treated with 1 µM
of PI3Kγ inhibitor AS605240 and infected with T. cruzi at a MOI 3:1 ratio followed
by an additional 48 h of incubation at 37 °C in a 5% CO2 incubator. After 48 h, the
cells were fixed and stained with Panótico (Laborclin®). The macrophage killing
activity was evaluated by counting (blinded) of intracellular amastigote forms
internalized per 50 cells. These cells were not contaminated with mycoplasma.
Nitrite and nitrate quantification. The nitrite concentration in the culture
supernatants of BMDM was determined using the conventional Griess reaction
method52. For the nitrate quantification assay, heart samples removed near the
papillary muscle were homogenized with a sonicator (Virsonic 100, Virtis, NY,
USA) in 200 μl of cold 0.1 N acetic acid, centrifuged for 5 min (9300 g) and the
supernatant used for measurement of nitrate and total protein by the Bradford
method. Subsequently, 25 µl of supernatant was deproteinized with 50 µl of cold
ethanol and maintained at −20 °C for 30 min. Then, the samples were centrifuged
(9300 g, 5 min) and the nitrate content was determined using a chemiluminescent
analyzer (Sievers 280 NO Analyzer, Boulder, CO, USA). The values are expressed
in µM nitrate per μg of protein.
In vivo cytotoxicity assay of CD8+ cells. Eighteen dpi, WT and Pik3cg−/− mice
intravenously received two populations of splenocytes from WT naive mice pre-
viously stained with two different concentrations of carboxyflourescein (CFSE—
Sigma Aldrich®). The first population was stained with CFSE at 10 μM (CFSE high)
and pulsed for 40 min with the T. cruzi peptide PA8, which is presented based on
class I MHC as the target of CD8+ cells. The second population stained with CFSE
at 1 μM (CFSE low) and not pulsed with any peptide was used as the control
population. Recipient WT and Pik3cg−/− mice were sacrificed approximately 16 h
after the cell transfer, and splenocytes were analyzed with a flow cytometer to
determine the percentage of CFSE high and low populations.
CD4+CD25+ suppression assay. CD4+ T-cells were isolated by negative selec-
tion from lymph nodes of WT mice using CD4 MACS beads Multisort (Miltenyi
Biotec), according to the manufacturer’s recommendations. Briefly, the non-CD4+
T-cells were labeled with a mix containing cocktail of biotin-conjugated antibodies
and anti-biotin monoclonal antibodies conjugated to microbeads. The magnetically
labeled cells were subsequently depleted by separation using AutoMacs Pro
Separator Cell sorter (Miltenyi Biotec). Next, CD4+ cells obtained were stained
with PE anti-mouse CD25 (1:200, clone PC61.5, eBioscience, cat. 12-0251-81) and
the CD25+ PE-labeled cells were incubated with anti-PE microBeads and isolated
by positive selection. Two distinct cell populations, CD4+CD25− (effectors T-cells)
and CD4+CD25+ (Tregs) were obtained. Tregs were cultured with T effectors cells
in a 96-well U-bottom plate (Costar®). The Teff cells were labeled with 1 μM Dye
Efluor 670 (eBioscience) for 15 min at 37 °C, washed, and then cultured (1 × 105
cells per well) for 4 days with a graded number of Tregs (Teff:Treg: 1:1, 1:2, 1:4, and
1:8) in the presence of soluble Purified hamster anti-mouse CD3e (3 μg/ml, Clone
145-2C11, BD Bioscience, cat. 553057) and Purified hamster anti-mouse CD28
(1.5 μg/mL, Clone 37.51, BD Bioscience, cat. 553294). Proliferation of Teff cells was
determined by dye dilution in FACS analysis. The results are expressed as the
percentage of suppression under each Treg:Teff ratio using the following formula:
[proliferation of Teff only–(proliferation of Teff+ Treg)/proliferation of Teff
only] × 100.
Patient samples and tissue collection. Experiments on human samples were
performed in accordance with the ethical standards established in the Declaration
of Helsinki. The protocol was approved by the Institutional Review Board of the
School of Medicine of São Paulo (CAPPesq-protocol number 0265-10) and the
Brazilian National Ethics in Research Commission (CONEP protocol number 009/
2011). Written informed consent was obtained from the patients. Tissue specimens
from the left ventricle free wall were obtained from individuals with end-stage heart
failure at the moment of heart transplantation (DCM patients, age 41.1 ± 15.63
years; mean ± SD). All patients with CCC (age 46.1 ± 9.33 years; mean ± SD) were
considered serologically positive for antibodies against T. cruzi based on the results
of at least two of three independent tests. They underwent standard electro-
cardiography and echocardiography. They presented with typical electro-
cardiography findings and had severe ventricular dysfunction, with a left
ventricular ejection fraction of <0.4. Similarly, human samples were obtained from
patients with idiopathic DCM characterized by severe ventricular dysfunction, an
absence of ischemic disease, and negative results of serologic tests for T. cruzi
infection. Finally, control biopsy specimens were obtained from healthy hearts of
organ donors (mean age 23 ± 4.69 years) for which there was no suitable recipient.
Human experiments were blinded with respect to the samples group.
Whole-transcriptome analysis. Whole-genome expression was performed with
the SurePrint G3 Human Gene Expression 8 × 60K arrays (Agilent Technologies,
Les Ulis, France), according to the manufacturer’s recommendations. Gene
expression data were deposited in the GEO database (GSE84796 and GSE111544).
Microarray analyses and signal normalization were performed with GeneSpring
software (11.5.1, Agilent). For each sample, the P-value was obtained using the
Student’s t-test and adjusted for the false discovery rate with the
Benjamini–Hochberg method. Genes were considered differentially expressed if
adjusted P-values were <0.05 and showed an absolute fold change >2.0.
Statistical analysis. Results are expressed as the mean ± s.e.m. for in vitro and
in vivo experiments. The normal distribution of data was analyzed by D’Agostino
and Pearson test. The data set obtained by experiments with mice or primary cells
assumed a normal distribution. Differences were considered to be statistically
significant with P < 0.05 by unpaired Student’s t-test or ANOVA followed by
Bonferroni post test. Survival curves were evaluated using the log-rank/
Mantel–Cox test. For analysis of the correlation, Pearson’s test was carried out. All
statistical analyses were performed using GraphPad Prism Software 5 except for the
analysis of correlation, for which SPSS was used. No statistical methods were used
to predetermine the sample size. Variation within each data set obtained by
experiments with mice or primary cells was assumed to be similar between gen-
otypes since all strains were generated and maintained on the same pure inbred
background (C57BL/6).
Data availability. The data supporting the findings of this study are available
within the article and its Supplementary Information files or from the corre-
sponding authors on reasonable request. RNA expression data are available at the
Gene Expression Omnibus repository (GSE84796); (GSE111544); and (GSE41089).
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